1045668

AptaPharma Inc. — FEI 3010164738

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 16, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Pennsauken, NJ (United States)